Clinical Trials Browser

Phase 2 × Recurrence × nintedanib × Clear all

NCT01610869 2019-05-29

METRO-BIBF

Phase 2 Completed

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Recurrence

NCT02558387 2015-11-20

Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck

Phase 2 Unknown

Recurrence

NCT01380782 2014-08-18

BIBF 1120 for Recurrent High-Grade Gliomas

Phase 2 Completed

37 enrolled 11 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Recurrence, Gliosarcoma